Literature DB >> 17376392

Macrophage migration inhibitory factor: a probable link between inflammation and cancer.

Richard Bucala1, Seamas C Donnelly.   

Abstract

The pleiotropic effects of macrophage migration inhibitory factor (MIF) place it in a central position in the immunopathogenesis of many diseases. Here we discuss the current understanding of MIF's role and highlight it as a potential link between inflammatory activation and malignant progression.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17376392     DOI： 10.1016/j.immuni.2007.03.005

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  78 in total

Review 1.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

Review 2.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

3.  MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.

Authors:  Priyadharsini Nagarajan; Kathleen L Tober; Judith A Riggenbach; Donna F Kusewitt; Amy M Lehman; Thais Sielecki; James Pruitt; Abhay R Satoskar; Tatiana M Oberyszyn
Journal:  Mol Cancer Res       Date:  2014-05-21       Impact factor: 5.852

Review 4.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

5.  A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

Authors:  Shouhui Yang; Peijun He; Jian Wang; Aaron Schetter; Wei Tang; Naotake Funamizu; Katsuhiko Yanaga; Tadashi Uwagawa; Abhay R Satoskar; Jochen Gaedcke; Markus Bernhardt; B Michael Ghadimi; Matthias M Gaida; Frank Bergmann; Jens Werner; Thomas Ried; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

6.  Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Authors:  Hui Liu; Gang Chen; Wei Zhang; Jun-Yi Zhu; Zhao-Quan Lin; Zhong-Cheng Gong; Feng-Qin Wang; Jun Jia; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

7.  A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.

Authors:  Günter Fingerle-Rowson; Dayananda Rao Kaleswarapu; Corinna Schlander; Nazanin Kabgani; Tania Brocks; Nina Reinart; Raymonde Busch; Anke Schütz; Hongqi Lue; Xin Du; Aihua Liu; Huabao Xiong; Yibang Chen; Alice Nemajerova; Michael Hallek; Jürgen Bernhagen; Lin Leng; Richard Bucala
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

8.  Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat.

Authors:  Pedro L Vera; Xihai Wang; Richard J Bucala; Katherine L Meyer-Siegler
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

9.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.

Authors:  Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

10.  Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.

Authors:  W Joost Wiersinga; Thierry Calandra; Liesbeth M Kager; Gerritje J W van der Windt; Thierry Roger; Didier le Roy; Sandrine Florquin; Sharon J Peacock; Fred C G J Sweep; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.